···
The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Image details File size:
23.9 MB (1 MB Compressed download)
Open your image file to the full size using image processing software.
Dimensions:
3543 x 2362 px | 30 x 20 cm | 11.8 x 7.9 inches | 300dpi
More information:
This image could have imperfections as it’s either historical or reportage.
Search stock photos by tags
Similar stock images The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094123.html RM 2KBM4F7 – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094152.html RM 2KBM4G8 – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094166.html RM 2KBM4GP – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094156.html RM 2KBM4GC – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094158.html RM 2KBM4GE – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094141.html RM 2KBM4FW – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094150.html RM 2KBM4G6 – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094121.html RM 2KBM4F5 – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094161.html RM 2KBM4GH – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094126.html RM 2KBM4FA – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094140.html RM 2KBM4FT – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) Stock Photo https://www.alamy.com/image-license-details/?v=1 https://www.alamy.com/the-spanish-medicines-agency-has-authorized-a-clinical-study-with-the-respira-emergency-respirator-designed-by-the-gpa-innova-company-it-is-a-company-that-has-honed-its-knowledge-of-creating-metal-polishing-machinery-to-develop-a-respirator-for-the-most-critical-patients-and-to-help-provide-hospitals-with-materials-to-deal-with-the-coronavirus-covid-19-crisis-gpainnova-estimates-that-it-will-initially-be-able-to-produce-150-to-200-units-daily-and-that-it-may-increase-its-production-to-300-units-per-day-photo-by-miquel-llopnurphoto-image489094162.html RM 2KBM4GJ – The Spanish Medicines Agency has authorized a clinical study with the Respira emergency respirator, designed by the GPA Innova company. It is a company that has honed its knowledge of creating metal polishing machinery to develop a respirator for the most critical patients and to help provide hospitals with materials to deal with the Coronavirus Covid-19 crisis. GPAInnova estimates that it will initially be able to produce 150 to 200 units daily, and that it may increase its production to 300 units per day. (Photo by Miquel Llop/NurPhoto) 
